Eidelman Virant Capital Abbott Laboratories Transaction History
Eidelman Virant Capital
- $136 Million
- Q3 2022
A detailed history of Eidelman Virant Capital transactions in Abbott Laboratories stock. As of the latest transaction made, Eidelman Virant Capital holds 3,100 shares of ABT stock, worth $348,440. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,100
Previous 3,100
-0.0%
Holding current value
$348,440
Previous $332,000
8.43%
% of portfolio
0.22%
Previous 0.24%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,135Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.36 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.07 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.43 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...